Can some advanced cancer kidney cancer patients be safely watched closely (without going for chemotherapy treatment straightaway).

A Canadian team presented data on this topic at the American Society of Clinical Oncology meeting at Chicago.

The team says it can be safely done in select group of patients without compromising the survival.

Delayed treatment without putting patients through nasty side effects is certainly a welcome option for some patients.

Reference

1. ASCO 2019: Abstract number 4516.

Session: Genitourinary (Nonprostate) Cancer. Type: Poster Discussion Session

Time: Monday June 3, 4:30 PM to 6:00 PM

Location: Hall D2

Active surveillance in metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis). 2019 ASCO Annual Meeting J Clin Oncol 37, 2019 (suppl; abstr 4516)